These results demonstrate that the inhibition of mitochondrial OXPHOS synthesis by CRIF1 downregulation has antitumor effects via TIGAR induction in BT549 TNBC cells (Figure 5), which has been investigated as a possible approach for cancer therapy. The gene discussed is GADD45GIP1; the disease is cancer.